NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Despite their confirmation of review and analysis of data ongoing on May 12 and May 18, and despite the unblinded data being first sent to statisticians, then summaries of unblinded results plus the data then going to the company and a multitude of experts for review and analysis, and despite Dr. Liau recently talking about hypothetical treatment survival curves far to the right of external controls, and despite Linda Powers asking investors to continue to wait patiently even after unblinding of data as explained above, ongoing review and analysis of results and data, and despite Sawston probably getting certified late summer early fall, the old timers here probably feel they placed enough pre-result investment in already, and potentially new investors and institutions are wait and see, probably because of the many misses on timing of final results by management.